Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Brazil sets out strategy for control dengue in 2003

This article was originally published in Clinica

Executive Summary

The Brazilian health ministry has set out ambitious goals for its R$1bn (US$331m) dengue control programme (PNCD) in 2003. At a meeting in Brasilia last week, the newly-created PNCD committee announced a target of halving this year's incidence of the disease, and of reducing to 1% the death rate associated with the haemorrhagic form of the condition. Early diagnosis is the key to controlling the disease in its milder form, following infection from one serotype, prior to its progression to the haemorrhagic form, through exposure to a different serotype (see Clinica No 1001, p 14).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT067746

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel